Fuji gets first install for FCR 5000 readerFuji Medical Systems North America has installed three FCR 5000 CR readers at the Ambulatory Care Center at the University of California, Davis Medical Center. The first institution to purchase Fuji's
Fuji Medical Systems North America has installed three FCR 5000 CR readers at the Ambulatory Care Center at the University of California, Davis Medical Center. The first institution to purchase Fuji's latest CR release, UC Davis installed the readers as the initial step in moving to a filmless environment, according to the Stamford, CT-based company. As part of this first phase of PACS implementation, UC Davis will be installing two more readers in the emergency room and four readers in the in-patient radiology department by the end of the year.
The FCR 5000 can accommodate up to four imaging plates via a multi-level plate stacker and can support throughput of up to 148 imaging plates per hour, according to the firm. It offers both standard and high- resolution processing modes, and can network multiple examination terminals to allow entry of demographic and examination information in the x-ray room, according to Fuji.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.